- Filed
- May 2, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Apr 30, 2024 | 62.62M sh |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $310.69M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $130.61M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $206.6M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $214.92M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $727.79M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $918.64M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $776.6M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $808.39M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $1.04B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $1.05B |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $71.29M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2023 | $169.72M |
| Stock Issued | Q1 2024 · Mar 31, 2023 | 0 sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 60.13M sh |
| Capex | Q1 2024 · Mar 31, 2023 | $2.58M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$122.96M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | −$2.15 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | −$2.15 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $70.95M |
| Rd Expense | Q1 2024 · Mar 31, 2023 | $112.07M |
| Net Income | Q1 2024 · Mar 31, 2023 | −$129.56M |
| Cost Of Revenue | Q1 2024 · Mar 31, 2023 | $3.18M |